Skip to main content
logo
Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.420
+0.030 (1.26%)
Jul 31, 2025, 11:41 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2021FY 2019FY 2018FY 20172016 - 2018
Period Ending
Dec '23 Dec '21 Dec '19 Dec '18 Dec '17 2016 - 2018
Gene Therapeutics
3.60M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapeutics Growth
-52.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2021FY 2019FY 2018FY 20172016 - 2018
Period Ending
Dec '23 Dec '21 Dec '19 Dec '18 Dec '17 2016 - 2018
United States
3.60M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-52.00%
Log In
Log In
Log In
Log In
Upgrade